Natalie Reizine

Also affiliated with University of Chicago

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy”.

Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2085

N/A

0DataRank · unranked

188 citations

Bryan Peterson, Anthony V. Serritella, Joseph Thomas, Natalie Reizine, Stephanie Moya +4 more

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

Cancer Discovery(2020)10.1158/2159-8290.cd-20-1408

N/A

0DataRank · unranked

71 citations

Stephanie Moya, Samantha Lomnicki, Leah M. Chase, Bryan Peterson, Natalie Reizine +19 more

Evaluation of spatiotemporal heterogeneity of tumor mutational burden (TMB) in gastroesophageal adenocarcinoma (GEA) at baseline diagnosis and after chemotherapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4546

N/A

0DataRank · unranked

7 citations

Bryan Peterson, Anthony V. Serritella, Natalie Reizine, Yan Wang, Daniel V.T. Catenacci +1 more

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4561

N/A

0DataRank · unranked

4 citations

Bryan Peterson, Leah M. Chase, Samantha Lomnicki, Anthony V. Serritella, Natalie Reizine +12 more

Evaluation of spatiotemporal heterogeneity of PDL1 expression in gastroesophageal adenocarcinoma (GEA) at baseline diagnosis and after chemotherapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4528

N/A

0DataRank · unranked

1 citations

Bryan Peterson, Anthony V. Serritella, Natalie Reizine, Yan Wang, Daniel V.T. Catenacci +1 more

Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients

The Oncologist(2021)10.1002/onco.13953

N/A

0DataRank · unranked

30 citations

Keith Danahey, Emily Schierer, Ping Liu, Merisa Middlestadt, Jenna Ludwig +7 more

Safety and efficacy of combining genotype-guided irinotecan (Iri) with 5FU, leucovorin (LV), oxaliplatin (Ox), and docetaxel (Tax) (gFOLFOXIRITAX): The I-FLOAT phase 1 dose-escalation study for advanced upper GI cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.316

N/A

0DataRank · unranked

0 citations

Aurelie Desgardin, Chih‐Yi Liao, Ardaman Shergill, Natalie Reizine, Stephanie Moya +11 more

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3471

N/A

0DataRank · unranked

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more